DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo
Market statusData NSENot investment advice
METROPOLIS HEALTHCARE

METROPOLIS HEALTHCARE Latest Share Price (METROPOLIS)

₹564.20
1.00−0.18%
Overall Score59/100
Day range563
₹564.20
581
52-week412
₹564.20
2,060
Above low+36.9%
Below high72.6%
Range position9%
Open564.50
Prev Close565.20
Bid564.17100
Ask564.23100

TODAY IN ONE LINE

METROPOLIS is little changed at ₹564.20 on average volume — a quiet consolidation day.

With a market cap of ₹11,716.99 Cr., it trades at a P/E of 52.20. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.

Volume196.3K−17%vs 20D avg
Price Band20
Lower Band424.5
Upper Band636.7
Tick Size0.05
Daily Volatility1.89%
Annualised Vol36.11%
Market Cap₹11,716.99 Cr.
Promoter47.82%
Face Value₹2
Fwd P/E35.66
PEG6.14
EV/EBITDA20.48
P/S7.06
ROA8.34%
Beta0.65
Div Payout21.81%
THE STOCK SCORE
Overall Score59/100
Updated 07 Sept

How good is this company?

Overall performance across 5 key dimensions.

Each card tappable → shows formula + inputs
FLAGS & NEWS

METROPOLIS HEALTHCARE flags & news 

Key strengths, potential risks, and recent updates.

✅ 6 green flags🚩 3 red flags

Green Flags

  • ●Earnings GrowthEPS (TTM) grew by a solid 73.0% YoY
  • ●Quarterly OutperformanceLatest quarter Sales up 10.3% and Profit up 32.7%
  • ●Healthy Operating MarginsOPM is structurally strong at 16.9%
  • ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
  • ●Positive Free Cash FlowFCF has been positive for 3 consecutive years
  • ●Zero Pledge RiskNo recent active promoter pledging found

Red Flags

  • ●Expensive ValuationTrading at a high P/E ratio of 58.9x
  • ●Promoter SellingPromoter holding decreased by 1.04% QoQ
  • ●Rising Receivables vs SalesReceivables grew 16.2% outpacing sales growth of 10.2%

Latest METROPOLIS HEALTHCARE News

THE CHANGELOG

What changed recently?

Recent events, corporate actions, and announcements.

10 NOV 2026
corporate
Analysts/Institutional Investor Meet/Con. Call Updates - Metropolis Healthcare Limited has informed the Exchange about Transcript
View PDF
10 NOV 2026
corporate
Analysts/Institutional Investor Meet/Con. Call Updates - Metropolis Healthcare Limited has informed the Exchange about Transcript
View PDF
🔒Prime: full history + alerts on this stock
Valuation

METROPOLIS HEALTHCARE valuation: P/E, P/B and sector benchmarks.

Twelve years of multiples investors have paid for METROPOLIS HEALTHCARE, framed against the sector median so the premium or discount is obvious at a glance.

METROPOLIS HEALTHCARE trades at a P/E of 52.20× and P/B of 7.13×.

Key MetricsMarket + reported · 13 Nov 2026Consolidated

Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.

Valuation

Valuation

Market Cap
₹11,716.99 Cr.
P/E Ratio
52.2
P/B Ratio
7.13
EPS
₹3.63
Profitability

Profitability

ROE
11.31%
ROCE
12.52%
Net Margin
11.55%
Op Margin
16.88%
Growth

Growth

EPS YoY
73%
Revenue YoY
23%
Qtr Sales
10.35%
Qtr Profit
32.7%
Financial Health

Financial Health

Debt / Equity
—
Book Value
₹73.49
Div Yield
0.18%
Promoter Holding
47.82%
Technicals

METROPOLIS HEALTHCARE technical analysis: indicators, pivots and CPR.

Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for METROPOLIS HEALTHCARE — derived from the latest tape, not yesterday's close.

METROPOLIS HEALTHCARE last traded at ₹564.2 with an intraday range of ₹562.7–₹580.65 — latest indicator, pivot and CPR signals below.

Last updated: 16 November 2026, 4:08 pm IST

Pivot points

Standard pivot — most widely referenced.

Pivot levels · Classic

Last: ₹564.20
LevelPrice (₹)Distance% Δ
R4611.57+47.37+8.40%
R3593.62+29.42+5.21%
R2587.13+22.93+4.06%
R1575.67+11.47+2.03%
PIVOT569.184.980.88%
CURRENT564.20——
S1557.72-6.48-1.15%
S2551.23-12.97-2.30%
S3539.77-24.43-4.33%
S4521.82-42.38-7.51%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: 566.69P: 569.18TC: 571.67
R1
R2
R3
R4
indicator
LTP: 564.20
PDH: 577.50
PDL: 564.15
● Market Sentiment

METROPOLIS is trading Below CPR, indicating Bearishness

● CPR Width

CPR is Wider, suggesting unlikely for trending moves

● Opening Range

Day's range: ₹564.5–₹580.65

● Price Position

Trading Inside opening range

Financials

METROPOLIS HEALTHCARE financials: P&L, balance sheet, cash flow, ratios.

Reported annual and quarterly results for METROPOLIS HEALTHCARE — consolidated or standalone — with margins, YoY growth and key ratios inline.

METROPOLIS HEALTHCARE reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹11,716.99 Cr. and reported EPS of ₹3.63.

iTap any row for a plain-English meaning▲▼Change vs a year ago — green means the move is healthy for that line, red means it isn’tDerivedCalculated by us, not reported directly
Mobile view
Latest vs previous year
MetricMar 2026May 2026
Revenue from Operations1,646
1,646
▲ 0.0%
Sales Growth YoY %Derived23.64%
23.64%
Other Income26
26
▲ 0.0%
Total Income1,671
1,671
▲ 0.0%
325
325
▲ 0.0%
Gross ProfitDerived1,321
1,321
▲ 0.0%
Gross Margin %Derived80.28%
80.28%
920
920
▲ 0.0%
EBITDA (Operating Profit)Derived401
401
▲ 0.0%
OPM %Derived24.36%
24.36%
149
149
▲ 0.0%
Profit Before Tax (PBT)259
259
▲ 0.0%
68
68
▲ 0.0%
Effective Tax %Derived26.23%
26.23%
Total Profit for Period191
191
▲ 0.0%
Less: Non-controlling Interests1
1
▲ 0.0%
Net Profit (Owner's PAT)Derived190
190
▲ 0.0%
Net Profit Margin %Derived11.55%
11.55%
PAT Growth YoY %Derived31.08%
31.08%
Earnings Per Share (EPS ₹)9.17
9.17
▲ 0.0%
Diluted Shares Outstanding (Cr)21
21
▲ 0.0%
Share of Profit from Associates/JVs—
—
Other Comprehensive Income (Net of Tax)5
5
▲ 0.0%
Total Expenses (incl. D&A & Interest)1,412
1,412
▲ 0.0%
Material Cost % of RevenueDerived19.72%
19.72%
Employee Cost % of RevenueDerived22.93%
22.93%
Other Cost % of RevenueDerived33.00%
33.00%
Interest Coverage (x)Derived10.88x
10.88x
Sales CAGR · 3Y
+7.3%
Sales CAGR · 5Y
+6.4%
PAT CAGR · 3Y
+9.4%
PAT CAGR · 5Y
+8.3%
all values in ₹ Cr unless marked % / x / ₹ · fiscal-period end shown · reported figures via Stockezee financials API · annual results may be audited; quarterly results may be unaudited or limited-review
Segment Analysis

METROPOLIS HEALTHCARE segment analysis : revenue and profit mix.

Disclosed business segments at METROPOLIS HEALTHCARE with their share of revenue and profit, switchable between consolidated and standalone reporting.

METROPOLIS HEALTHCARE discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.

Segment-wise Financial Analysis

Thesis

The Bull, Bear, and Flip case for METROPOLIS HEALTHCARE.

Our AI distills the core fundamental drivers supporting METROPOLIS HEALTHCARE, the risks that threaten it, and the quantitative conditions that could weaken the thesis.

bull case

What you're getting.

No strengths or opportunities on record.

bear case

Key Risks.

No weaknesses or threats on record.

flip conditions

Flip Conditions.

  • Valuation risk. a P/E above 68 would leave less room for earnings disappointment.

  • Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.

  • Return-quality risk. ROE below 8% would indicate weaker capital compounding.

  • Income thesis breaks if the dividend is cut or yield falls below 0.09%.

Shareholding

METROPOLIS HEALTHCARE shareholding pattern: promoters, FII, DII and public.

Quarter-on-quarter ownership shifts in METROPOLIS HEALTHCARE — who is buying, who is exiting, and which institutions hold the largest positions.

Shareholding Pattern

Annual • Sep 2026

FII11.67%↑0.64%
Promoters47.82%↓1.04%
Public5.02%↑0.03%
DII35.49%↑0.37%

Ownership Distribution

Foreign Institutions
11.67%
Promoters
47.82%
Retail & Public
5.02%
Domestic Institutions
35.49%

Category Trends

Foreign Institutions Breakdown
Total Holding: 11.67%
Net Change: +0.64%
Category Total11.67%
Total Holding11.67%
Net Change+0.64%
Not Fully Disclosed

⚠️Partial Disclosure Notice

Individual institutions below total 0.00%, but category aggregate is 11.67%. Some institutions may not be disclosed by the company as per regulatory requirements.

Institution Name
Trend (Last 6)
Holding %
QoQ Change
YoY ChangePeriod
Smallcap World Fund, Inc
0.00%
0.00%
0.00%
Sep 2026
Fundsmith Emerging Equities Trust Plc
0.00%
0.00%
0.00%
Sep 2026
Wasatch International Opportunities Fund
0.00%
0.00%
0.00%
Sep 2026
Caisse De Depot Et Placement Du Quebec - First Sentier Investors International Im Limited
0.00%
0.00%
0.00%
Sep 2026
J P MORGAN FUNDS
0.00%
0.00%
0.00%
Sep 2026
Grandeur Peak International Stalwarts Fund
0.00%
0.00%
0.00%
Sep 2026
The Scottish Oriental Smaller Companies Trustplc
0.00%
0.00%
0.00%
Sep 2026
Jpmorgan Indian Investment Trust Plc
0.00%
0.00%
0.00%
Sep 2026
Caisse De Depot Et Placement Du Quebec - First State Investments International Limited
0.00%
0.00%
0.00%
Sep 2026
Fssa Indian Subcontinent Fund As Sub Fund Of First Sentier Investors Global Umbrella Fund Plc
0.00%
0.00%
0.00%
Sep 2026
Neuberger Berman Emerging Markets Equity Fund
0.00%
0.00%
0.00%
Sep 2026
Peers

METROPOLIS HEALTHCARE peer comparison — same-sector benchmarks.

Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — METROPOLIS HEALTHCARE is highlighted for quick read-across.

Quick Compare

Largest by Market Cap
DR. LAL PATH LABS
₹33,301.21 Cr
Best Profit Growth
KRSNAA DIAGNOSTICS
48.55 %
Highest Dividend Yield
THYROCARE TECH
1.41 %
09 · Chart Patterns

METROPOLIS HEALTHCARE chart patterns: breakouts, tops and bottoms.

Auto-detected classical chart patterns for METROPOLIS HEALTHCARE — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.

Delivery Conviction

METROPOLIS HEALTHCARE delivery volume — last 20 sessions of conviction.

Daily traded volume and delivery percentage for METROPOLIS HEALTHCARE over 20 sessions — the gap between intraday flipping and genuine accumulation.

Latest session delivery in METROPOLIS HEALTHCARE stood at 48.5% of traded volume, against a 20-day average of 54.7%.

Avg Delivery (20D)54.7%-6.2 ppt latest vs avg
Highest Delivery69.5%on 06 Nov
Avg Volume (20D)2.37 L20-day run-rate
Conviction Trend↓ Weakening-6.2 ppt latest read
Volume & Delivery · last 20 sessions
Exchange Filings & Investor Updates

METROPOLIS HEALTHCARE announcements: results, concalls, ratings, M&A.

Filings METROPOLIS HEALTHCARE sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.

METROPOLIS HEALTHCARE files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 185 documents below.

  1. 10 Nov 2026Analysts/Institutional Investor Meet/Con. Call UpdatesView PDF

    Analysts/Institutional Investor Meet/Con. Call Updates

    Metropolis Healthcare Limited has informed the Exchange about Transcript

  2. 05 Nov 2026Analysts/Institutional Investor Meet/Con. Call UpdatesView PDF

    Analysts/Institutional Investor Meet/Con. Call Updates

    Metropolis Healthcare Limited has informed the Exchange about meeting with investors scheduled on November 16, 2026

  3. 04 Nov 2026Analysts/Institutional Investor Meet/Con. Call UpdatesView PDF

    Analysts/Institutional Investor Meet/Con. Call Updates

    Metropolis Healthcare Limited has informed the Exchange about Link of Recording

  4. 04 Nov 2026Copy of Newspaper PublicationView PDF

    Copy of Newspaper Publication

    Metropolis Healthcare Limited has informed the Exchange about Copy of Newspaper Publication

  5. 03 Nov 2026Press ReleaseView PDF

    Press Release

    Metropolis Healthcare Limited has informed the Exchange regarding a press release dated November 03, 2026, titled "Metropolis Healthcare reports…

Corporate Actions

METROPOLIS HEALTHCARE dividend history, splits and bonus issues.

Every dividend, stock split and bonus issue METROPOLIS HEALTHCARE has declared, sequenced by announce and record date.

METROPOLIS HEALTHCARE corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.

Insider Activity

METROPOLIS HEALTHCARE insider trading: promoter and management activity.

Promoter, director and designated-employee transactions in METROPOLIS HEALTHCARE as reported to SEBI — buying and selling signals from the people who know the business best.

METROPOLIS HEALTHCARE insider activity below tracks 4 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).

InsiderCategoryTxn DateActionQuantityValue (₹)Price
Sushil Shah Family TrustInsider29 May 2025buy+11.67 L——
Sushil Kanubhai ShahInsider29 May 2025sell−11.67 L——
Duru Shah Family TrustInsider26 Mar 2025buy+7.66 L——
Dr. Duru Sushil ShahInsider26 Mar 2025sell−7.66 L——
About the Company

About METROPOLIS HEALTHCARE: business, sector, key facts.

What METROPOLIS HEALTHCARE does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.

METROPOLIS HEALTHCARE operates in the Healthcare Service Provider industry under the Healthcare sector, listed as NSE: METROPOLIS, BSE: 542650.

METROPOLIS
Healthcare

METROPOLIS HEALTHCARE

NSE · METROPOLIS·BSE · 542650·www.metropolisindia.com

Metropolis Healthcare Limited is a leading provider of diagnostic services in India and internationally. Their core business revolves around offering a comprehensive range of clinical laboratory testing and profiling services to individuals and corporate clients. This includes a wide array of tests designed for various medical specialties and purposes.

The company's services cater to a broad spectrum of medical needs. They provide diagnostic services specializing in oncology (cancer), neurology (nervous system), gynecology (women's health), and nephrology (kidney disease). This specialized focus allows them to offer highly targeted and accurate testing for a variety of health conditions.

Beyond specialized testing, Metropolis also offers a comprehensive suite of health check-up packages. These packages are tailored to different demographic groups, including men, women, senior citizens, youth, and corporate employees. This approach allows for preventative health measures and early detection of potential health problems.

The diagnostic services provided by Metropolis play a crucial role in various stages of healthcare. Their tests are used for disease prediction, early detection through screening, confirming diagnoses, and monitoring the progression of existing conditions. This comprehensive approach contributes significantly to effective healthcare management.

In addition to their core diagnostic services, Metropolis also offers corporate wellness programs. These programs are designed to improve the health and well-being of employees within organizations. They also provide laboratory information system services and support clinical research initiatives, further expanding their reach within the healthcare ecosystem.

company facts
Employees—
SectorHealthcare
HeadquartersMumbai, India
Market Cap₹11,716.99 Cr.
Listed OnNSE
leadership35 on record
Dr. Aparna Rajadhyaksha
Non-Executive Non-Independent Director
Dr. H. N. Ravikumar
Managing Director of RV Metropolis
Dr. Kirti Chadha
Chief Scientific Officer, Innovation Officer and Group Head CSR
Dr. Kirti Chadha
Chief Scientific & Innovation Officer
Dr. Kirti Chadha
Chief Scientific & Innovation Officer and Group Head of CSR
Dr. Nilesh Jadavji Shah
President of Internal Assurance & Advisor to CEO
Dr. Nilesh Shah
President Internal Assurance and Advisor to Chief Executive Officer
Dr. Sushil Kanubhai Shah
Founder, Non-Executive Director & Chairman Emeritus
Dr. Sushil Shah
Non-Executive Non-Independent Director
Mr. Avadhut Joshi
Chief Business Development Officer
Mr. Bhoopendra Rajawat
Chief Business Officer - West, North and East India
Mr. Hemant Sachdev
Non-Executive Non-Independent Director
§ ∞ · Plainly Answered

Questions investors ask about METROPOLIS HEALTHCARE (METROPOLIS).

Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.

01What is the current share price of METROPOLIS HEALTHCARE (METROPOLIS)?

The current share price of METROPOLIS HEALTHCARE (METROPOLIS) is ₹564.20. Today, the stock has declined by ₹1.00 (0.18%), trading in a range of ₹562.70 to ₹580.65. The stock opened at ₹564.50 with a trading volume of 1,96,267 shares.

02Is METROPOLIS HEALTHCARE stock a good investment for long-term?

METROPOLIS HEALTHCARE can be considered for long-term investment based on several factors. The company has a market capitalization of ₹11,716.99 Cr., P/E ratio of 52.2, ROE of 11.31%, and ROCE of 12.52%. The dividend yield stands at 0.18%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.

03What is the 52-week high and low price of METROPOLIS HEALTHCARE stock?

The 52-week high price of METROPOLIS HEALTHCARE (METROPOLIS) is ₹2,060.00, while the 52-week low is ₹412.25. Currently trading at ₹564.20, the stock is 36.86% above its 52-week low and 72.61% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.

04Should I buy METROPOLIS HEALTHCARE stock at the current price?

Whether to buy METROPOLIS HEALTHCARE stock at ₹564.20 depends on multiple factors. The stock is currently trading with a P/E ratio of 52.2 and P/B ratio of 7.13. Today's performance shows a loss of 0.18%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.

05What is the dividend yield of METROPOLIS HEALTHCARE and when is the next dividend?

METROPOLIS HEALTHCARE offers a dividend yield of 0.18%, which means for every ₹100 invested at the current price of ₹564.20, you can expect to receive approximately ₹0.18 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.

06What are the key financial ratios and metrics of METROPOLIS HEALTHCARE?

METROPOLIS HEALTHCARE's key financial metrics include: P/E Ratio: 52.2, P/B Ratio: 7.13, ROE: 11.31%, ROCE: 12.52%, Dividend Yield: 0.18%, EPS: ₹3.63, Book Value: ₹73.49, and Debt-to-Equity: 0. The company's market cap stands at ₹11,716.99 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.

07How is METROPOLIS HEALTHCARE stock performing today in the market?

METROPOLIS HEALTHCARE stock opened at ₹564.50 and is currently trading at ₹564.20, showing a decline of ₹1.00 (0.18%). The intraday high is ₹580.65 and low is ₹562.70. The trading volume stands at 1,96,267 shares, indicating moderate market participation today.

08What is the P/E ratio of METROPOLIS HEALTHCARE and what does it indicate?

METROPOLIS HEALTHCARE has a Price-to-Earnings (P/E) ratio of 52.2, which means investors are willing to pay 52.20 for every ₹1 of earnings. With an EPS of ₹3.63, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.

Disclaimer

The data, ratios and commentary about METROPOLIS HEALTHCARE (METROPOLIS) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.